未登录 分享 收藏
分享 收藏
Long term results and ctDNA correlatives for CAPOX BETR: A multi-center phase II trial of capecitabine, oxaliplatin, bevacizumab and trastuzumab for previously untreated HER2 positive metastatic gastroesophageal adenocarcinoma Singh, Harshabad; Lowder, Kristen E.; Kapner, Kevin; Kelly, Ronan J.; Zheng, Hui; McCleary, Nadine J.; Abrams, Thomas A.; Chan, Jennifer A.; Regan, Eileen M.; Klempner, Samuel J.; Hannigan, Alison M.; Brais, Lauren K.; Andrews, Elizabeth A.; Yurgelun, Matthew B.; Cleary, James M.; Rubinson, Douglas A.; Ritterhouse, Lauren L.; Maron, Garrett E.; Aguirre, Andrew J.; Tan, Lu; Du, Pan; Meyerhardt, Jeffrey A.; Gardecki, Emma; Lennerz, Jochen K.; Jia, Shidong; Wolpin, Brian M.; Enzinger, Peter C. 分享 收藏
Targeted liquid biopsy mutation profiling and genome-wide cfDNA copy-number landscape in 3000 samples from six major cancer indications Gould, Billie; Tan, Lu; Dai, Chao; Zheng, Tiantian; Mo, Wei; Wang, Xianghong; Sneddon, Michael; Jia, Shidong; Zhou, Kemin; Du, Pan 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Germline Mutational Landscape in Chinese Patients With Advanced Breast Cancer Zhang, Jiayang; Wang, Nan; Zheng, Tiantian; Lu, Tan; Zhang, Ruyan; Ran, Ran; Li, Kun; Huang, Yong; Xie, Feng; Zhang, Yue; Jia, Shidong; Yu, Jianjun; Li, Huiping 分享 收藏
Blood tumor mutational burden (bTMB) and blood copy number burden (bCNB) by genome-wide circulating tumor DNA (ctDNA) assessment predict outcome and resistance in hormone-receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with CDK4/6 inhibitor (CDK4/6i) Davis, Andrew; Luo, Jingqin; Zheng, Tiantian; Tan, Lu; Wang, Amy; Suresh, Rama; Ademuyiwa, Foluso; Rigden, Caron; Rearden, Timothy; Clifton, Katherine; Weilbaecher, Katherine; Frith, Ashley; Tandra, Pavan K.; Summa, Tracy; Haas, Brittney; Thomas, Shana; Hernandez-Aya, Leonel; Peterson, Lindsay; Luo, Shujun; King, Bonnie L.; Jia, Shidong; Yu, Jianjun; Du, Pan; Krishnamurthy, Jairam; Ma, Cynthia X.; Dai, C. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏